| Schedule of Stock Option Activity and Related Information |
The following table summarizes the activity for options that vest solely based upon the satisfaction of a service condition as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | Options outstanding | | Weighted-average exercise price | | Weighted-average remaining contractual life (in years) | | Aggregate intrinsic values (in thousands) (1) | | Balance as of March 31, 2023 | 1,024,490 | | | $ | 16.17 | | | | | | | Exercised | (347,590) | | | 14.47 | | | | | | | Canceled or forfeited | (2,900) | | | 26.84 | | | | | | | Balance as of March 31, 2024 | 674,000 | | | $ | 17.01 | | | 3.3 | | $ | 120,660 | | | Exercised | (68,334) | | | 13.95 | | | | | | | Balance as of March 31, 2025 | 605,666 | | | $ | 17.35 | | | 2.3 | | $ | 27,519 | | | Exercised | (271,752) | | | 16.26 | | | | | | | Balance as of March 31, 2026 | 333,914 | | | $ | 18.24 | | | 1.9 | | $ | 14,146 | | | | | | | | | | | Exercisable, March 31, 2026 | 333,914 | | | $ | 18.24 | | | 1.9 | | $ | 14,146 | |
(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the Company's closing stock price of $60.61, as reported on the New York Stock Exchange on March 31, 2026. The following table summarizes the activity for options that vest based upon the satisfaction of performance or market conditions as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Options outstanding | | Weighted-average exercise price | | Weighted-average remaining contractual life (in years) | | Aggregate intrinsic values (in thousands) (1) | | Balance as of March 31, 2023 | 517,740 | | | $ | 14.46 | | | | | | | Exercised | (256,440) | | | 1.84 | | | | | | | Balance as of March 31, 2024 | 261,300 | | | $ | 26.84 | | | 2.9 | | $ | 44,209 | | | Exercised | — | | | — | | | | | | | Balance as of March 31, 2025 | 261,300 | | | $ | 26.84 | | | 1.9 | | $ | 9,394 | | | Exercised | (48,300) | | | 26.84 | | | | | | | Balance as of March 31, 2026 | 213,000 | | | $ | 26.84 | | | 0.9 | | $ | 7,193 | | | | | | | | | | | Exercisable, March 31, 2026 | 213,000 | | | $ | 26.84 | | | 0.9 | | $ | 7,193 | |
(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the Company's closing stock price of $60.61, as reported on the New York Stock Exchange on March 31, 2026.
|
| Schedule of Additional Information Relating to Stock Options Activity |
Additional information relating to service-based options is as follows (in thousands): | | | | | | | | | | | | | | | | | | | Fiscal year ended March 31, | | | 2026 | | 2025 | | 2024 | | Stock-based compensation expense | $ | 37 | | | $ | 74 | | | $ | 147 | | | Intrinsic value of options exercised | 30,010 | | | 9,314 | | | 45,542 | | | | | | | |
Additional information relating to options that vest based upon the satisfaction of performance or market conditions is as follows (in thousands): | | | | | | | | | | | | | | | | | | | Fiscal year ended March 31, | | 2026 | | 2025 | | 2024 | | | | | | | | Intrinsic value of options exercised | $ | 5,291 | | | $ | — | | | $ | 27,718 | | | | | | | |
|
| Schedule of Activities for Restricted Stock Awards ("RSAs") and Restricted Stock Units ("RSUs") |
The following table summarizes the activities for restricted stock awards (“RSAs”) and restricted stock units (“RSUs”), including performance-based RSUs, as follows: | | | | | | | | | | | | | | Shares of restricted stock outstanding | | Weighted-average grant date fair value | | Balance as of March 31, 2023 | 2,128,773 | | | $ | 25.94 | | | Granted | 526,280 | | | 111.41 | | | Vested | (649,592) | | | 24.57 | | | Canceled or forfeited | (62,594) | | | 51.75 | | | Balance as of March 31, 2024 | 1,942,867 | | | $ | 48.67 | | | Granted | 642,615 | | | 130.34 | | | Vested | (963,266) | | | 39.17 | | | Canceled or forfeited | (68,494) | | | 102.03 | | | Balance as of March 31, 2025 | 1,553,722 | | | $ | 85.98 | | | Granted | 1,174,451 | | | 88.64 | | | Vested | (1,083,297) | | | 45.41 | | | Canceled or forfeited | (123,219) | | | 109.64 | | | Balance as of March 31, 2026 | 1,521,657 | | | $ | 115.02 | |
|
| Schedule of Additional Information Related to RSAs and RSUs |
Additional information relating to RSAs and RSUs (including performance-based RSUs), is as follows (in thousands): | | | | | | | | | | | | | | | | | | | Fiscal year ended March 31, | | | 2026 | | 2025 | | 2024 | | Stock-based compensation expense: | | | | | | | Cost of sales | $ | 12 | | | $ | 54 | | | $ | 16 | | | Selling, general and administrative expense | 86,907 | | | 71,732 | | | 40,462 | | | Total | $ | 86,919 | | | $ | 71,786 | | | $ | 40,478 | | | | | | | | | Intrinsic value of restricted stock released | $ | 86,138 | | | $ | 170,037 | | | $ | 73,124 | |
|